화학공학소재연구정보센터
Biochemical and Biophysical Research Communications, Vol.342, No.2, 379-386, 2006
alpha B-crystallin mutation in dilated cardiomyopathy
Mutations in genes for sarcomeric proteins such as titin/connectin are known to cause dilated cardiomyopathy (DCM). However, disease-causing mutations can be identified only in a small proportion of the patients even in the familial cases, suggesting that there remains yet unidentified disease-causing gene(s) for DCM. To explore the novel disease gene for DCM, we examined CRYAB encoding alpha B-crystallin for mutation in the patients with DCM, since aB-crystallin was recently reported to associate with the heart-specific N2B domain and adjacent 126/127 domain of titin/connectin, and we previously reported a N2B mutation, Gln4053ter, in DCM. A missense mutation of CRYAB, Arg157His, was found in a familial DCM patient and the mutation affected the evolutionary conserved amino acid residue among alpha-crystallins. Functional analysis revealed that the mutation decreased the binding to titin/connectin heart-specific N2B domain without affecting distribution of the mutant crystallin protein in cardiomyocytes. In contrast, another CRYAB mutation, Arg120Gly, reported in desmin-related myopathy decreased the binding to both N2B and striated muscle-specific 126/27 domains and showed intracellular aggregates of the mutant protein. These observations suggest that the ArQ157His mutation may be involved in the pathogenesis of DCM via impaired accommodation to the heart-specific N2B domain of titin/connectin and its disease-causing mechanism is different from the mutation found in desmin-related myopathy. (c) 2006 Elsevier Inc. All rights reserved.